Showing results (21-30 of 58) with videos related to
Sort By:
Pageof 6
Trauma Case Reports|January 31, 2023
Posterior sternoclavicular joint dislocation with thoracic costovertebral joints fracture-dislocations: A case reportHiroshi Takahashi, Shinsuke Takeda, Ryutaro Shibata, et al.[Rinsho Ketsueki] the Japanese Journal of Clinical Hematology|December 18, 2007
[Frequency and prognostic value of chromosome abnormalities in multiple myeloma]Shingo Kurahashi, Akiyo Sawamoto, Takumi Sugimoto, et al.International Journal of Hematology|January 29, 2018
Outcomes of strategic alternative donor selection or suspending donor search based on Japan Marrow Donor Program coordination statusNaomi Kawashima, Satoshi Nishiwaki, Naoko Shimizu, et al.Nagoya Journal of Medical Science|January 19, 2026
Leg dominance affects the appearance of osteoarthritis of the lumbar facet joints at L5-SShunsuke Kanbara, Tomohiro Matsumoto, Takayuki Sugino, et al.Gan to Kagaku Ryoho. Cancer & Chemotherapy|October 18, 2007
[Efficacy and safety of induction chemotherapy consisting of anthracycline for 3 days and cytarabine for 7 days in elderly patients with acute myeloid leukemia]Shingo Kurahashi, Toshihiro Iwasaki, Hitoshi Suzuki, et al.Internal Medicine (Tokyo, Japan)|October 21, 2021
A Retrospective Analysis of R-MPV Plus Response-adapted Whole-brain Radiotherapy for Elderly Patients with Primary Central Nervous System LymphomaYutaro Suzuki, Naoto Imoto, Shunichi Ishihara, et al.[Rinsho Ketsueki] the Japanese Journal of Clinical Hematology|August 8, 2020
[Lupus anticoagulant-hypoprothrombinemia syndrome associated with follicular lymphoma]Daisuke Koyama, Ryo Hanajiri, Takeshi Kanematsu, et al.The Journal of Biological Chemistry|December 26, 2015
B Cell Linker Protein (BLNK) Is a Selective Target of Repression by PAX5-PML Protein in the Differentiation Block That Leads to the Development of Acute Lymphoblastic LeukemiaNaoto Imoto, Fumihiko Hayakawa, Shingo Kurahashi, et al.Leukemia Research|December 15, 2015
A new prognostic index to make short-term prognoses in MDS patients treated with azacitidine: A combination of p53 expression and cytogeneticsSatoshi Nishiwaki, Masafumi Ito, Rie Watarai, et al.American Journal of Hematology|April 2, 2009
Combinations of cytogenetics and international scoring system can predict poor prognosis in multiple myeloma after high-dose chemotherapy and autologous stem cell transplantationYoshihiro Inamoto, Shingo Kurahashi, Nobuhiko Imahashi, et al.Pageof 6